| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,728 |
2,711 |
$143K |
| 99215 |
Prolong outpt/office vis |
2,131 |
1,195 |
$73K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,868 |
1,380 |
$34K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
177 |
143 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
36 |
25 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
317 |
176 |
$406.88 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30 |
24 |
$180.31 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
14 |
$145.23 |
| 86710 |
|
22 |
15 |
$129.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$100.59 |
| 36415 |
Collection of venous blood by venipuncture |
41 |
37 |
$78.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23 |
14 |
$75.46 |
| 82947 |
|
28 |
24 |
$72.80 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
31 |
28 |
$57.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19 |
12 |
$39.35 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
15 |
$8.59 |
| 99072 |
|
16 |
13 |
$0.00 |